Both in Biotechnology
Solid Biosciences vs Cullinan Therapeutics
Over the past year SLDB returned +24.3% and CGEM returned +59.2%; their daily moves had a correlation of 0.35.
SLDB +24.3% CGEM +59.2%Growth of $1, one year, split-adjusted
| Metric | SLDB | CGEM |
|---|---|---|
| Price | $6.47 | $12.44 |
| Market cap | $693.2M | $800.3M |
| Today | +2.95% | −21.05% |
| 1 month | −6.6% | −23.5% |
| 6 months | −10.2% | −17.0% |
| Year to date | +14.6% | +20.1% |
| 1 year | +24.3% | +59.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $377.7M | $334.5M |
| Dividend yield | — | — |
| Volatility (60d) | 68.2% | 88.1% |
| Short % of float | 17.8% | 14.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).